Evaluating the safety of anti‐amyloid monoclonal antibody infusions in alternative sites of care
Christine Miller, Don Filibeck, Lauren Pica, Barbara Prosser · 2025
Read Evaluating the safety of anti‐amyloid monoclonal antibody infusions in alternative sites of care by Christine Miller, Don Filibeck, Lauren Pica, Barbara Prosser (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11712763.txt.
Description
Christine Miller and co-authors published a research paper in 2025 on the safety of giving new Alzheimer's antibody drugs outside big hospitals. The drugs are given by drip and can be delivered at home or at a local infusion center, which saves money and travel. Their pharmacy team reviewed a year of such care across the country.
Thirty patients got 194 infusions in all, some at home and the rest at local centers. About one drip in seven brought a reaction, most often a drop in blood pressure or a headache. No drip had to be stopped, and nurses saw no severe allergy signs. The team reads the record as a good sign for care closer to home.
Catalog record
| CREATOR | Christine Miller, Don Filibeck, Lauren Pica, Barbara Prosser |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |